GS
Gagnon Securities’s Vanda Pharmaceuticals VNDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-18,131
| Closed | -$325K | – | 96 |
|
|
2017
Q3 | $325K | Hold |
18,131
| – | – | 0.12% | 68 |
|
|
2017
Q2 | $296 | Sell |
18,131
-60
| -0.3% | -$1 | 0.08% | 67 |
|
|
2017
Q1 | $255K | Sell |
18,191
-208
| -1% | -$2.92K | 0.11% | 79 |
|
|
2016
Q4 | $293K | Sell |
18,399
-191
| -1% | -$3.04K | 0.13% | 76 |
|
|
2016
Q3 | $309K | Sell |
18,590
-22,307
| -55% | -$371K | 0.13% | 75 |
|
|
2016
Q2 | $458K | Sell |
40,897
-242
| -0.6% | -$2.71K | 0.21% | 56 |
|
|
2016
Q1 | $344K | Hold |
41,139
| – | – | 0.16% | 62 |
|
|
2015
Q4 | $383K | Hold |
41,139
| – | – | 0.18% | 55 |
|
|
2015
Q3 | $464K | Sell |
41,139
-22,149
| -35% | -$250K | 0.23% | 53 |
|
|
2015
Q2 | $803K | Sell |
63,288
-3,629
| -5% | -$46K | 0.32% | 46 |
|
|
2015
Q1 | $622K | Buy |
66,917
+550
| +0.8% | +$5.11K | 0.21% | 53 |
|
|
2014
Q4 | $950K | Sell |
66,367
-8,245
| -11% | -$118K | 0.3% | 38 |
|
|
2014
Q3 | $774K | Sell |
74,612
-17,826
| -19% | -$185K | 0.26% | 46 |
|
|
2014
Q2 | $1.5M | Sell |
92,438
-18,680
| -17% | -$302K | 0.48% | 30 |
|
|
2014
Q1 | $1.81M | Sell |
111,118
-23,158
| -17% | -$376K | 0.54% | 29 |
|
|
2013
Q4 | $1.67M | Sell |
134,276
-9,804
| -7% | -$122K | 0.5% | 32 |
|
|
2013
Q3 | $1.58M | Sell |
144,080
-7,085
| -5% | -$77.6K | 0.49% | 32 |
|
|
2013
Q2 | $1.22M | Buy |
+151,165
| New | +$1.22M | 0.44% | 31 |
|